Skip to main
ABT
ABT logo

Abbott Labs (ABT) Earnings Dates & Reports

Abbott Labs (ABT) Most Recent Earnings

Report DateOct 15, 2025
Period EndingQ3 2025
Est. EPS$1.30
Actual EPS$1.30
EarningsMeet

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Abbott Labs (ABT) Earnings per Share (EPS) History

Signup for full access
Browse free

Abbott Labs (ABT) Latest Earnings

The value each ABT share was expected to gain vs. the value each share gained.

Abbott Labs (ABT) reported its most recent earnings on Oct 15, 2025 for Q3 2025, posting earnings per share (EPS) of $1.30. This exceeded analysts' expectations of $1.30 by 0.00%, marking a Meet.

For comparison, Abbott Labs reported EPS of $1.21 in the same quarter last year.

The company is expected to announce its next earnings report on 01/21/2026, with analysts projecting an EPS of $1.50.

Abbott Labs (ABT) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Jan 21, 2026
$1.50Next earnings call Jan. 21, 2026
Q3 2025Oct 15, 2025
$1.30$1.300.00%
Q2 2025Jul 17, 2025
$1.25$1.26+0.80%
Q1 2025Apr 16, 2025
$1.07$1.09+1.87%
Q4 2024Jan 22, 2025
$1.34$1.340.00%
View all

Abbott Labs (ABT) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Abbott Labs’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Oct 15, 2025
Jul 17, 2025
Apr 16, 2025
Jan 22, 2025

Abbott Labs (ABT) Earnings FAQs

Abbott Labs (ABT) last reported earnings on Oct 15, 2025 for Q3 2025, posting an EPS of $1.30, which Meet the estimate of $1.30 by 0.00%.

For Q3 2025, Abbott Labs (ABT) reported an EPS of $1.30, missing analysts' estimate of $1.30 by 0.00%.

For Q3 2025, Abbott Labs (ABT) Meet expectations with an actual EPS of $1.30 vs. an estimated EPS of $1.30.

Following the last earnings report on Oct 15, 2025, Abbott Labs (ABT)'s stock price moved — from — to —.

The next Abbott Labs (ABT) earnings call is scheduled for Jan. 21, 2026, where executives will discuss financial results and outlook.

Abbott Labs (ABT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.